Skip to content

Clinical trials

Phase 3 Pulmonary Fibrosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Fibrosis Phase: Phase 3 Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20032
20071
20081
20091
20112
20131
20151
20173
20191
20203
20222
20232
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Terminated7
Active, not recruiting2
Recruiting2
Unknown status2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb3
InterMune3
Boehringer Ingelheim2
Duke University2
Kyntra Bio2
Alexandria University1
Assistance Publique - Hôpitaux de Paris1
Bellerophon Pulse Technologies1
Fernando J Martinez1
Instituto Nacional de Cardiologia Ignacio Chavez1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Fibrosis25
Idiopathic Pulmonary Fibrosis13
Lung Diseases5
Lung Diseases, Interstitial5
Fibrosis3
Connective Tissue Diseases2
Hypertension, Pulmonary2
Idiopathic Interstitial Pneumonias2
Respiratory Distress Syndrome2
Scleroderma, Diffuse2

Trials

Showing 76 to 25 of 25. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.